Home » Topics » BioWorld Science

BioWorld Science
RSS

Researchers develop a novel murine model of Cockayne syndrome

Jan. 14, 2022

Everest Medicines licenses global rights to EDDC's 3CL protease inhibitors to treat COVID-19

Jan. 14, 2022

Sage Therapeutics discloses new GABA-A receptor modulators

Jan. 14, 2022

Gilead Sciences synthesizes new HIV antivirals

Jan. 14, 2022

X4 Pharmaceuticals presents new CXCR4 antagonists

Jan. 14, 2022

Medshine Discovery divulges new GTPase KRAS G12C mutant inhibitors

Jan. 14, 2022

Icahn School of Medicine at Mount Sinai patents DYRK1A inhibitors

Jan. 14, 2022

Antibodies against SIRPA and SIRPB1 promote antitumoral effect in preclinical study

Jan. 14, 2022

RBD-PB6 RNA aptamer blocks SARS-CoV-2 entry into host cells

Jan. 14, 2022

Modulation of IL-19 regulates DNA damage-induced cytokine production

Jan. 13, 2022

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...